State of Alaska, Department of Revenue - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$344
-27.1%
12,837
-3.1%
0.00%
-33.3%
Q2 2023$472
+24.5%
13,252
-11.2%
0.01%
+50.0%
Q1 2023$379
-36.3%
14,923
+1.6%
0.00%
-42.9%
Q4 2022$595
-99.9%
14,6880.0%0.01%0.0%
Q3 2022$485,000
-9.2%
14,688
-3.2%
0.01%0.0%
Q2 2022$534,000
-21.7%
15,173
+2.2%
0.01%0.0%
Q1 2022$682,000
-31.8%
14,843
-1.7%
0.01%
-30.0%
Q4 2021$1,000,000
+0.1%
15,093
-5.7%
0.01%0.0%
Q3 2021$999,000
-25.4%
16,003
-1.0%
0.01%
-28.6%
Q2 2021$1,339,000
+24.2%
16,172
-0.6%
0.01%
+16.7%
Q1 2021$1,078,000
-15.8%
16,262
-2.6%
0.01%
-20.0%
Q4 2020$1,280,000
+70.4%
16,694
-4.4%
0.02%
+66.7%
Q3 2020$751,000
-3.8%
17,457
-3.5%
0.01%
-10.0%
Q2 2020$781,000
+57.5%
18,097
+4.9%
0.01%
+25.0%
Q1 2020$496,000
-52.4%
17,251
+4.8%
0.01%
-42.9%
Q4 2019$1,043,000
-49.4%
16,455
-77.5%
0.01%
-50.0%
Q3 2019$2,063,000
+141.3%
73,212
+126.9%
0.03%
+100.0%
Q2 2019$855,00032,2650.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders